The government intends to launch Jan Samarth, a unified platform for the delivery of multiple initiatives with the objective of minimum government maximal governance.
Serum Institute of India (SII) to manufacture the indigenously-developed India's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer. The Drugs Controller General of India (DCGI) approved India's first Quadri-valent Human Papillomavirus vaccine (qHPV) against cervical cancer.
EXAMIANS